MedElevator Войти в исследования
← Поиск публикаций

DOI 10.17219/acem/132069

Медицинская библиотека · Advances in clinical and experimental medicine : official organ Wroclaw Medical University · 2021

Wharton's jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata.

Czarnecka Anna, Odziomek Agnieszka, Murzyn Magdalena, Dubis Joanna, Bagłaj-Oleszczuk Marta, Hryncewicz-Gwóźdź Anita

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Alopecia areata (AA) is the second most common cause of non-scarring alopecia. Little is known on the etiopathogenesis of AA. It is considered an autoimmune disease, with T lymphocytes and antibodies directed against hair follicle structures. Topical and systemic therapies are used for the treatment of AA, but none of the therapies used to date have a permanent therapeutic effect.

OBJECTIVES

To evaluate the efficacy and safety of AA treatment through a single intradermal injection of a suspension of allogeneic MSCs extracted from Wharton's jelly (WJ-MSCs) into the alopecia foci.

MATERIAL AND

METHODS

The study involved 4 AA patients who underwent experimental therapy with a suspension of WJ-MSCs. The AA intensity was measured using the SALT score. This measure was performed 3 times during treatment: 1st measure (SALT0) prior to treatment; 2nd measure (SALT12) 12 weeks after the treatment; and 3rd measure (SALT24) 24 weeks after the treatment. Furthermore, during each follow-up visit (6, 12, 18, and 24 weeks after the administration of WJ-MSCs) the patient's general condition (physical examination) and local condition were assessed, their mood was evaluated, and a photo of the scalp was taken.

RESULTS

Hair regrowth was observed in all patients by an average of 67% at the sites where the cell suspension was administered. In all cases, we observed greater dynamics of hair regrowth in the first 3 months after the treatment, with an average increase of 52.2%, compared to the following 3 months, with an average of 32%.

CONCLUSIONS

The results of the applied intradermal injections of an allogeneic WJ-MSC suspension were positive with hair growth observed in all participants and the therapy was found to be safe, with no side effects.

Для цитирования: Czarnecka Anna, Odziomek Agnieszka, Murzyn Magdalena, Dubis Joanna, Bagłaj-Oleszczuk Marta, Hryncewicz-Gwóźdź Anita. Wharton's jelly-derived mesenchymal stem cells in the treatment of four patients with alopecia areata.. Advances in clinical and experimental medicine : official organ Wroclaw Medical University. 2021. DOI: 10.17219/acem/132069.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.